SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,231.00    7.00 (0.57%)
Bid:
1,229.00
Ask:
1,230.00
Spread: 1.00 (0.081%)
Market Cap: £858.56m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisitions/Trading Update

13 Dec 2007 07:01

CVS Group plc13 December 2007 For Immediate Release 13 December 2007 CVS Group plc ("CVS" or "the Group") Acquisitions and Pre-close Trading Update Acquisitions CVS, one of the UK's leading providers of veterinary services, is pleased toannounce three single site practice acquisitions located in Kidsgrove inStaffordshire, Fleet in Hampshire and Doncaster. The practices achieved aggregate EBITDA of £276,000 on turnover of £1.986m fortheir respective latest financial reporting periods. The consideration, which isnot being disclosed for reasons of commercial sensitivity, is being satisfiedwholly in cash. The acquired practices employ a total of 10 vets bringing the Group total toalmost 300. Commenting on the acquisitions, CVS Chief Executive Simon Innes said "Each ofthese three practices enjoys a strong reputation for clinical care and we lookforward to developing an excellent long term relationship with their respectiveteams". Pre-close Trading Update With five months of the current financial year now behind us the Board isdelighted to report continued strong progress on all fronts. We started the financial year with 43 small animal practices operating from 120surgeries and with one equine specialist practice and three veterinarydiagnostic laboratories. In the period up to flotation in early October weacquired a further two small animal practices operating from seven surgerieswhich, together with the significant number of acquisitions made in the secondhalf of last financial year, gave us a substantially higher EBITDA run-rate thanthe actual historic EBITDA of £5.1m achieved for the year ended 30 June 2007. Since flotation we have acquired a further four small animal practices,including the three announced today, operating from six surgeries and employing24 vets. Our pipeline of potential acquisitions remains strong, assisted by thedemographics which have now been prevalent in the sector for a few years. We will remain focused on acquiring well established practices achievingexcellence in terms of clinical care and where each practice employs at leastthree vets. The central services provided by the Group remain very attractive tovets, enabling individual surgeries to focus on clinical care. Our organic growth continues to be firm and we are confident of achievinganother year of significant progress in executing our strategy. Contacts:CVS Group plc 01379 644 288Simon Innes, Chief ExecutivePaul Coxon, Finance Director Buchanan CommunicationsRichard Oldworth 0207 466 5000Suzanne Brocks 07776 234 600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Jun 202611:08 amRNSHolding(s) in Company
12th Jun 202610:06 amRNSHolding(s) in Company
8th Jun 20262:43 pmRNSStandard form for notification of major holdings
8th Jun 20262:41 pmRNSUpdated: Transaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSPDMR Dealing
26th May 20267:02 amRNSChanges to NEDs' Responsibilities
26th May 20267:01 amRNSCommencement of Share Buyback Programme
26th May 20267:00 amRNSRefinancing, Launch of SBB and Acquisition
8th May 20263:55 pmRNSStandard form for notification of major holdings
30th Apr 20267:00 amRNSTotal Voting Rights
21st Apr 202612:46 pmRNSNon-Executive Director Appointment
20th Apr 20264:45 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSCEO retirement
25th Mar 20267:00 amRNSNon-Executive Director Changes
24th Mar 20267:13 amRNSResponse to CMA Summary Final Decision Report
27th Feb 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSTotal Voting Rights
29th Jan 20262:02 pmRNSStandard form for notification of major holdings
29th Jan 20268:00 amRNSReadmission - CVS Group Plc
29th Jan 20267:00 amRNSAdmission to Trading on the Main Market of the LSE
28th Jan 20267:08 amRNSResponse to DEFRA consultation
27th Jan 20262:31 pmRNSStandard form for notification of major holdings
23rd Jan 202612:19 pmRNSPublication of Prospectus and Trading Update
23rd Jan 20267:00 amRNSProgramme completion and transaction in own shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20269:51 amRNSStandard form for notification of major holdings
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:24 pmRNSStandard form for notification of major holdings
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSBlock Listing Interim Review
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20264:31 pmRNSStandard form for notification of major holdings
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20269:34 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.